• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia.

Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia. Pediatr Blood Cancer. 2015 Jul; 62(7):1270-6.

View in: PubMed

subject areas
  • Adolescent
  • Alemtuzumab
  • Anemia, Aplastic
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Male
  • Prognosis
  • Prospective Studies
  • Quality of Life
  • Survival Rate
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Unrelated Donors

authors with profiles
  • Jennifer Joi Jaroscak